The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion of cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...

Purdue Pharma filed a new bankruptcy plan on Tuesday ... use their settlement payments to address the harms of the opioid crisis. The plan will provide around $850 million for individuals harmed ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of opi ...

After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors more than $7.4 billion of cash to compensate ...

Utah has more than half a billion dollars in opioid settlement funds to allocate over the next 15 years, aiming to combat addiction effectively.

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...

Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a ...